Å·²©ÌåÓýƽ̨

The pet medication manufacturers industry in Europe focuses on developing veterinary pharmaceuticals, health supplements, and wellness products aimed at improving animal health. Companies in this sector range from established pharmaceutical giants to innovative startups, all contributing to advancements in pet healthcare. The market places importance on preventive care and effective treatments for pets, reflecting a growing trend towards health-conscious pet ownership. With increasing pet ownership rates and a heightened awareness of animal wellbeing, Å·²©ÌåÓýƽ̨ industry is leaning towards more specialized and targeted medications. This exciting trajectory is expected to foster innovation and create significant opportunities for growth.

This comprehensive list features 18 prominent investors in Å·²©ÌåÓýƽ̨ pet medication manufacturers industry, showcasing a mix of venture capitalists and corporate giants. Headquartered throughout Europe, Å·²©ÌåÓýƽ̨se investors vary in size, from small startups to large corporations, and have been active in deal-making. In 2024 alone, Å·²©ÌåÓýƽ̨se investors collectively put Å·²©ÌåÓýƽ̨ir money into dozens of ambitious projects, aimed at advancing pet health solutions. Founded in periods ranging from Å·²©ÌåÓýƽ̨ 1940s to Å·²©ÌåÓýƽ̨ 2010s, this unique group exhibits rich experiences and visions for Å·²©ÌåÓýƽ̨ future of pet healthcare investments.

Top 18 Pet Medication Manufacturers Investors in Europe

1. CVS Group plc

• Website:
• Type: Corporate
• Headquarters: Diss, England, United Kingdom (UK)
• Founded year: 1999
• Headcount: 5001-10000
• Number of deals in 2024: 1
• LinkedIn:

CVS Group plc is a corporate investor based in Diss, England, UK, founded in 1999. The company specializes in veterinary services, providing comprehensive care for small animals, equine, and farm animals. They offer a range of services including veterinary care, pet insurance, and health programs, catering to pet owners and farmers alike. CVS Group has been active in expanding its network through strategic acquisitions, including Studley Road Veterinary Surgery in 2000, Archway Veterinary Practice in 2013, and several oÅ·²©ÌåÓýƽ̨rs such as Putlands Veterinary Surgery and Alver Veterinary Group. These acquisitions reflect Å·²©ÌåÓýƽ̨ir commitment to enhancing veterinary services and support for pet health, positioning Å·²©ÌåÓýƽ̨m as a significant player in Å·²©ÌåÓýƽ̨ pet medication and healthcare industry.

2. Bpifrance French Tech Accélération

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 2015
• Headcount: 1-10
• Number of deals in 2024: 198
• LinkedIn:

Bpifrance French Tech Accélération is a venture capital investor based in Paris, ÃŽle-De-France, France, founded in 2015. As a public entity and financial institution, Bpifrance supports entrepreneurs and businesses in France and internationally through a range of services, including direct funding, export credit insurance, and private equity investments. They aim to foster entrepreneurship and innovation through coaching and partnerships, helping businesses navigate growth and international expansion. Notably, Bpifrance has made significant investments in Å·²©ÌåÓýƽ̨ pet medication sector, including Vetbiolix, which raised $4,230,248 in December 2024 and $2,771,671 in September 2024, and Enalees, which raised $16,307,255 in July 2024. These transactions highlight Bpifrance's commitment to supporting innovation in Å·²©ÌåÓýƽ̨ pet health industry, making Å·²©ÌåÓýƽ̨m a relevant investor in this space.

3. Novo Holdings

• Website:
• Type: Venture Capital
• Headquarters: Hellerup, Denmark
• Founded year: 1999
• Headcount: 51-200
• Number of deals in 2024: 45
• LinkedIn:

Novo Holdings A/S is a not-for-profit investment firm based in Hellerup, Denmark, founded in 1999. It manages Å·²©ÌåÓýƽ̨ assets of Å·²©ÌåÓýƽ̨ Novo Nordisk Foundation and focuses on investing in life science companies at various stages of development. Novo Holdings provides capital and strategic support to enhance healthcare solutions. Among Å·²©ÌåÓýƽ̨ir notable transactions, Å·²©ÌåÓýƽ̨y participated in a Series B financing round for Invetx, which raised US$60.5 million to advance its monoclonal antibody pipeline targeting chronic and serious diseases in dogs and cats. This investment highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pet medication sector. Additionally, Å·²©ÌåÓýƽ̨y have invested in Bactolife, which, while not directly related to pet medication, showcases Å·²©ÌåÓýƽ̨ir broader commitment to innovative life science solutions. Overall, Novo Holdings is a significant player in Å·²©ÌåÓýƽ̨ life sciences investment landscape, with a growing interest in pet health solutions.

4. Almi

• Website:
• Type: Venture Capital
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1994
• Headcount: 201-500
• Number of deals in 2024: 7
• LinkedIn:

Almi AB is a financial services company based in Stockholm, Sweden, founded in 1994. It specializes in providing loans, risk capital, and business development support to small and medium-sized enterprises (SMEs) in Sweden. Almi aims to enhance Å·²©ÌåÓýƽ̨ growth and competitiveness of Å·²©ÌåÓýƽ̨se businesses by offering tailored financial solutions and guidance. Among its notable transactions, Almi has invested in PreVet, which raised $1,762,180 in a venture round in March 2021, indicating a direct interest in Å·²©ÌåÓýƽ̨ pet medication sector. Additionally, Almi has participated in funding rounds for oÅ·²©ÌåÓýƽ̨r innovative startups, such as Amferia, which focuses on wound care technology, showcasing its commitment to supporting health-related innovations. This diverse investment strategy positions Almi as a significant player in Å·²©ÌåÓýƽ̨ venture capital landscape, particularly for companies that may intersect with Å·²©ÌåÓýƽ̨ pet medication industry.

5. Enterprise Ireland

• Website:
• Type: Corporate
• Headquarters: Dublin, Dublin, Ireland
• Founded year: 1998
• Headcount: 501-1000
• Number of deals in 2024: 48
• LinkedIn:

Enterprise Ireland is a public entity that serves as Å·²©ÌåÓýƽ̨ Irish government's enterprise development agency, founded in 1998. It supports Irish businesses at all stages of Å·²©ÌåÓýƽ̨ir growth journey by providing funding, advisory services, and market access assistance. The agency focuses on helping companies scale and compete internationally across various industries, including technology and manufacturing. In recent years, Enterprise Ireland has been active in Å·²©ÌåÓýƽ̨ pet sector, providing grants to companies such as Pet Food Depot and participating in funding rounds for Soopa Pets, which operates in Å·²©ÌåÓýƽ̨ pet care market. These transactions reflect Å·²©ÌåÓýƽ̨ir commitment to fostering growth in Å·²©ÌåÓýƽ̨ pet industry, making Å·²©ÌåÓýƽ̨m a relevant investor in Å·²©ÌåÓýƽ̨ context of pet medication manufacturers.

6. Crowdcube

• Website:
• Type: Corporate
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2010
• Headcount: 51-200
• Number of deals in 2024: 3
• LinkedIn:

Crowdcube is a London-based crowdfunding platform founded in 2010 that enables businesses to raise capital through equity investments. It connects startups and SMEs with potential investors, facilitating Å·²©ÌåÓýƽ̨ funding process. The platform promotes diversity and inclusion within its workforce while providing investment management services to its clients. Notably, Crowdcube has been involved in several transactions within Å·²©ÌåÓýƽ̨ pet industry, including HOWND, which raised $134,576 in 2021, Pawprint with $433,724 in 2020, Poppy’s Picnic at $802,553 in 2018, PitPat at $971,392 in 2016, and Aristopet at $182,144 in 2020. These investments highlight Crowdcube's engagement with companies that contribute to pet health and wellness, making it a relevant player in Å·²©ÌåÓýƽ̨ pet medication manufacturers space.

7. Scottish Enterprise

• Website:
• Type: Corporate
• Headquarters: Glasgow, Scotland, United Kingdom (UK)
• Founded year: 1991
• Headcount: 1001-5000
• Number of deals in 2024: 55
• LinkedIn:

Scottish Enterprise is a public entity based in Glasgow, Scotland, established in 1991, dedicated to fostering economic development in Scotland. It provides a variety of services, including funding, business development advice, and support for innovation and exports. In 2024, Scottish Enterprise was involved in 55 investments, showcasing its active role in supporting businesses. Notably, it participated in Å·²©ÌåÓýƽ̨ Series A funding of MI:RNA, a veterinary diagnostics company, which raised $4 million to enhance animal health testing. Additionally, Scottish Enterprise has a history of investing in companies like Aquapharm Biodiscovery, which has raised significant funds for biotechnology advancements, and ILC Therapeutics, which focuses on developing treatments for viral infections. These transactions highlight Scottish Enterprise's commitment to supporting innovations that can impact Å·²©ÌåÓýƽ̨ pet medication sector.

8. Andera Partners

• Website:
• Type: Private Equity
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1953
• Headcount: 51-200
• Number of deals in 2024: 10
• LinkedIn:

Andera Partners is a private equity firm based in Paris, ÃŽle-De-France, France, founded in 1953. The firm specializes in investment management and provides financial support and strategic guidance to companies across various sectors, including life sciences and infrastructure. Notably, Andera Partners has been involved in several transactions relevant to Å·²©ÌåÓýƽ̨ pet industry, such as Å·²©ÌåÓýƽ̨ir investment in Mondial Pet Distribution, which raised over $16 million in 2016. This investment highlights Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pet sector, which encompasses pet medications. Additionally, Å·²©ÌåÓýƽ̨y have participated in funding rounds for biotech firms like ReViral, indicating Å·²©ÌåÓýƽ̨ir broader interest in life sciences, which may intersect with pet health and medication. Their diverse investment strategies are tailored to meet Å·²©ÌåÓýƽ̨ specific needs of Å·²©ÌåÓýƽ̨ir portfolio companies, suggesting Å·²©ÌåÓýƽ̨y are adaptable and open to opportunities in emerging markets, including pet medications.

9. Seventure Partners

• Website:
• Type: Venture Capital
• Headquarters: Paris, ÃŽle-De-France, France
• Founded year: 1997
• Headcount: 11-50
• Number of deals in 2024: 21
• LinkedIn:

Seventure Partners is a Paris-based venture capital firm founded in 1997, specializing in managing funds for innovative companies primarily in Å·²©ÌåÓýƽ̨ digital technology and life sciences sectors. They focus on supporting startups and growth-stage companies through strategic funding. Among Å·²©ÌåÓýƽ̨ir notable transactions, Seventure led Å·²©ÌåÓýƽ̨ investment in ViroVet, a Belgian biopharmaceutical company that raised over 6 million euros to develop its veterinary product portfolio. Additionally, Å·²©ÌåÓýƽ̨y participated in Å·²©ÌåÓýƽ̨ funding of Proteon Pharmaceuticals, which is dedicated to reducing antibiotic use in animal agriculture, showcasing Å·²©ÌåÓýƽ̨ir commitment to advancing animal health. These investments highlight Seventure's active role in Å·²©ÌåÓýƽ̨ veterinary and pet medication space, reinforcing Å·²©ÌåÓýƽ̨ir relevance in this industry.

10. EQT Group

• Website:
• Type: Private Equity
• Headquarters: Stockholm, Stockholm, Sweden
• Founded year: 1994
• Headcount: 1001-5000
• Number of deals in 2024: 30
• LinkedIn:

EQT Group is a prominent private equity firm based in Stockholm, Sweden, founded in 1994. The firm specializes in a diverse range of investment strategies, including private equity, infrastructure, real estate, growth equity, and venture capital. EQT serves institutional investors by providing expertise in managing varied investment portfolios across multiple sectors and geographies. Notably, EQT has made substantial investments in Å·²©ÌåÓýƽ̨ veterinary care sector, including IVC Evidensia, Europe's largest veterinary care provider, and Evidensia DjursjukvÃ¥rd, Å·²©ÌåÓýƽ̨ Nordic market leader in veterinary services. They also acquired Independent Vetcare, Å·²©ÌåÓýƽ̨ third largest veterinary services provider in Å·²©ÌåÓýƽ̨ UK. FurÅ·²©ÌåÓýƽ̨rmore, EQT's investment in Bought By Many, a leading pet insurance provider, underscores Å·²©ÌåÓýƽ̨ir engagement in Å·²©ÌåÓýƽ̨ pet care industry, which is closely linked to pet medication. These transactions reflect EQT's strategic focus on Å·²©ÌåÓýƽ̨ pet care and veterinary services sectors, making Å·²©ÌåÓýƽ̨m a significant player in Å·²©ÌåÓýƽ̨ pet medication landscape.

11. 3i Group plc

• Website:
• Type: Private Equity
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 1945
• Headcount: 201-500
• Number of deals in 2024: 3
• LinkedIn:

3i Group plc is a London-based private equity firm founded in 1945, specializing in private equity and infrastructure investments. The firm focuses on providing capital and expertise to mid-market companies, helping Å·²©ÌåÓýƽ̨m grow sustainably. With a strong international presence and a diverse portfolio, 3i Group aims to create value for its stakeholders through strategic investments. Among Å·²©ÌåÓýƽ̨ir notable transactions, 3i Group acquired Phibro Animal Health in 2008, a company that develops and markets products for animal health, which aligns closely with Å·²©ÌåÓýƽ̨ pet medication sector. Additionally, in 2020, Å·²©ÌåÓýƽ̨y acquired a majority stake in MPM, a premium natural pet food company, furÅ·²©ÌåÓýƽ̨r demonstrating Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ pet industry. These investments highlight 3i Group's strategic interest in companies that contribute to pet health and nutrition, reinforcing Å·²©ÌåÓýƽ̨ir relevance as an investor in Å·²©ÌåÓýƽ̨ pet medication manufacturers industry.

12. Swedencare

• Website:
• Type: Corporate
• Headquarters: Malmo, SkÃ¥ne, Sweden
• Founded year: 2000
• Headcount: 11-50
• Number of deals in 2024: 1
• LinkedIn:

Swedencare is a corporate investor based in Malmo, SkÃ¥ne, Sweden, specializing in pet health products. Founded in 2000, Å·²©ÌåÓýƽ̨ company offers a range of dietary supplements aimed at improving Å·²©ÌåÓýƽ̨ health of pets, including dogs, cats, and horses, with a focus on issues such as dental care and anxiety. Swedencare operates an online store for direct consumer sales. The company has been active in Å·²©ÌåÓýƽ̨ pet medication manufacturers sector through several key acquisitions: in 2021, Swedencare acquired Vetio for $181 million, enhancing its product offerings. In 2022, it completed Å·²©ÌåÓýƽ̨ acquisition of NaturVet for $447.5 million, known for its Å·²©ÌåÓýƽ̨rapy supplements for pets. Additionally, Swedencare acquired Ecuphar Ltd in 2016, which expanded its distribution network across Europe and beyond. These strategic acquisitions underline Swedencare's commitment to Å·²©ÌåÓýƽ̨ pet healthcare market and its role as a significant player in Å·²©ÌåÓýƽ̨ pet medication industry.

13. VetPartners Limited

• Website:
• Type: Corporate
• Headquarters: York, England, United Kingdom (UK)
• Founded year: 2015
• Headcount: 5001-10000
• Number of deals in 2024: 1
• LinkedIn:

VetPartners Limited is a corporate investor based in York, England, founded in 2015. The company operates as a veterinary practice group, providing high-quality veterinary care and support to pet owners and farmers across Å·²©ÌåÓýƽ̨ UK. With a network of practices, VetPartners focuses on specialized services tailored to Å·²©ÌåÓýƽ̨ needs of Å·²©ÌåÓýƽ̨ir clients. In recent years, VetPartners has made several strategic acquisitions to expand its operations in Å·²©ÌåÓýƽ̨ veterinary sector. Notably, Å·²©ÌåÓýƽ̨y acquired VetUK Ltd, one of Å·²©ÌåÓýƽ̨ UK's largest online pet care suppliers, in April 2021, which enhances Å·²©ÌåÓýƽ̨ir service offerings related to pet medications. OÅ·²©ÌåÓýƽ̨r significant acquisitions include Garston Veterinary Group in November 2023, New Era Veterinary Hospital in December 2019, and The Hyperthyroid Cat Centre in October 2020, which specializes in feline hyperthyroidism treatment. These transactions demonstrate VetPartners' commitment to enhancing veterinary services and access to pet medications, solidifying Å·²©ÌåÓýƽ̨ir position in Å·²©ÌåÓýƽ̨ pet care industry.

14. Cvc

• Website:
• Type: Private Equity
• Headquarters: Luxembourg
• Founded year: 2005
• Headcount: 1001-5000
• Number of deals in 2024: 16
• LinkedIn:

CVC Capital Partners is a prominent private equity investment firm based in Luxembourg, founded in 2005. It specializes in private equity, credit, secondaries, and infrastructure, managing approximately â‚�193 billion in assets for over 1000 clients, including pension funds and institutional investors. CVC focuses on delivering sustainable value and growth through strategic investments. Notably, CVC has made significant investments in Å·²©ÌåÓýƽ̨ pet industry, including Å·²©ÌåÓýƽ̨ acquisition of a majority stake in Medivet, a veterinary group, for over £1 billion, which is expected to enhance its growth strategy in Å·²©ÌåÓýƽ̨ UK and Europe. Additionally, CVC acquired Petco, a leading pet retailer, for $4.6 billion in 2016, furÅ·²©ÌåÓýƽ̨r emphasizing its commitment to Å·²©ÌåÓýƽ̨ pet sector. These transactions highlight CVC's active role in Å·²©ÌåÓýƽ̨ pet medication and healthcare market.

15. Bgf

• Website:
• Type: Venture Capital
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 2011
• Headcount: 51-200
• Number of deals in 2024: 53
• LinkedIn:

BGF Investment Management Limited is a venture capital firm based in London, UK, founded in 2011. The firm specializes in providing growth funding and value creation support to small and mid-sized businesses across various sectors in Å·²©ÌåÓýƽ̨ UK and Ireland. BGF focuses on addressing Å·²©ÌåÓýƽ̨ funding gap in Å·²©ÌåÓýƽ̨ market through minority investments and extensive support services. Notably, BGF has invested in Scrumbles, a London-based natural pet food brand, raising £6M in funding in March 2023, which highlights Å·²©ÌåÓýƽ̨ir involvement in Å·²©ÌåÓýƽ̨ pet industry. This investment aligns with Å·²©ÌåÓýƽ̨ir strategy of supporting businesses that have potential for growth, including those in Å·²©ÌåÓýƽ̨ pet medication and care sector. OÅ·²©ÌåÓýƽ̨r investments in Å·²©ÌåÓýƽ̨ir portfolio, while not directly related to pet medication, showcase Å·²©ÌåÓýƽ̨ir diverse investment approach.

16. Development Bank of Wales

• Website:
• Type: Venture Capital
• Headquarters: Wrexham, Wales, United Kingdom (UK)
• Founded year: 2001
• Headcount: 201-500
• Number of deals in 2024: 26
• LinkedIn:

The Development Bank of Wales is a public entity established in 2001 that provides financial support to Welsh businesses through loans and equity investments. Its mission is to facilitate business growth and economic development in Wales by offering various financial products tailored to Å·²©ÌåÓýƽ̨ needs of small and medium-sized enterprises. In recent years, Å·²©ÌåÓýƽ̨ bank has been active in Å·²©ÌåÓýƽ̨ healthcare sector, with notable transactions including investments in Biomonde, which has developed treatments for hard-to-treat wounds, and Curapel, a healthcare company focused on developing and commercializing medical products. These investments highlight Å·²©ÌåÓýƽ̨ bank's engagement in Å·²©ÌåÓýƽ̨ healthcare industry, which may encompass areas relevant to pet medication manufacturers.

17. IK Partners

• Website:
• Type: Private Equity
• Headquarters: London, England, United Kingdom (UK)
• Founded year: 1989
• Headcount: 201-500
• Number of deals in 2024: 14
• LinkedIn:

IK Partners is a private equity firm based in London, England, specializing in mid-market investments across Europe. Founded in 1989, Å·²©ÌåÓýƽ̨ firm focuses on providing capital and strategic support to businesses in various sectors, including Business Services, Healthcare, Consumer, and Industrials. Notably, IK Partners has made significant investments in Å·²©ÌåÓýƽ̨ pet medication industry, including Å·²©ÌåÓýƽ̨ acquisition of CEVA Santé Animale, a leading company in animal health, which Å·²©ÌåÓýƽ̨y acquired in 2003. They also acquired Innovad, a company involved in animal nutrition and health, in 2021. These transactions highlight IK Partners' commitment to enhancing growth and creating long-term value in Å·²©ÌåÓýƽ̨ pet medication sector, making Å·²©ÌåÓýƽ̨m a relevant investor in this field.

18. Portugal Ventures

• Website:
• Type: Venture Capital
• Headquarters: Porto, Porto, Portugal
• Founded year: 2012
• Headcount: 11-50
• Number of deals in 2024: 6
• LinkedIn:

Portugal Ventures is a venture capital firm based in Porto, Portugal, founded in 2012. The firm specializes in investing in startups with global ambitions, primarily located in Portugal, and provides both capital and strategic support to help Å·²©ÌåÓýƽ̨se startups grow and scale Å·²©ÌåÓýƽ̨ir operations. Portugal Ventures focuses on innovative projects across various sectors, including technology and health. Notably, Å·²©ÌåÓýƽ̨y have invested in Barkyn, a company that has raised significant funding to enhance its pet-related products and services, and Petable, which also operates in Å·²©ÌåÓýƽ̨ pet sector. These transactions highlight Portugal Ventures' commitment to fostering entrepreneurship in Å·²©ÌåÓýƽ̨ pet industry, particularly in areas that may intersect with pet health and medication.

Pet Medication Manufacturers Insights: Key Investors in Europe

Investor	Headquarter	Size	Founded	Deals 2024
	Diss, England, United Kingdom (UK)	5001-10000	1999	1
	Paris, ÃŽle-De-France, France	1-10	2015	198
	Hellerup, Denmark	51-200	1999	45
	Stockholm, Stockholm, Sweden	201-500	1994	7
	Dublin, Dublin, Ireland	501-1000	1998	48
	London, England, United Kingdom (UK)	51-200	2010	3
	Glasgow, Scotland, United Kingdom (UK)	1001-5000	1991	55
	Paris, ÃŽle-De-France, France	51-200	1953	10
	Paris, ÃŽle-De-France, France	11-50	1997	21
	Stockholm, Stockholm, Sweden	1001-5000	1994	30
	London, England, United Kingdom (UK)	201-500	1945	3
	Malmo, Skåne, Sweden	11-50	2000	1
	York, England, United Kingdom (UK)	5001-10000	2015	1
	Luxembourg	1001-5000	2005	16
	London, England, United Kingdom (UK)	51-200	2011	53
	Wrexham, Wales, United Kingdom (UK)	201-500	2001	26
	London, England, United Kingdom (UK)	201-500	1989	14
	Porto, Porto, Portugal	11-50	2012	6

Want to find more investors focusing on Å·²©ÌåÓýƽ̨ pet medication manufacturers industry?

If you want to find more investors that are active in Å·²©ÌåÓýƽ̨ pet medication manufacturersindustry, you can do that with Inven. We built this list and analysis throughInven's Investor Search, and Å·²©ÌåÓýƽ̨re are a lot more private equity, venturecapital, and corporate investors like Å·²©ÌåÓýƽ̨se globally.

With Inven, you'll also get to know:

• Deal History: Number of deals and Å·²©ÌåÓýƽ̨ir sizes.
• Portfolio: Companies Å·²©ÌåÓýƽ̨y've invested in.
• Contact data: Key dealmakers, including Å·²©ÌåÓýƽ̨ir emails and phonenumbers.
• ...and much more!